BiomX Inc. (PHGE) Reports Q1 EPS of $0.28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BiomX (PHGE) PT Lowered to $2 at Ladenburg Thalmann
May 22, 2024 6:50 AM EDTLadenburg Thalmann analyst Mike Higgins lowered the price target on BiomX (NYSE: PHGE) to $2.00 (from $4.00) while maintaining a Buy rating.
The analyst comments "Yesterday, BiomX reported 1Q24 financials including EPS of -$0.28 vs consensus of -$0.07 and our -$0.16 estimate. Excluding a non-cash... More
